JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB37259

Anti-Cathepsin K antibody [3F9]

Be the first to review this product! Submit a review

|

(45 Publications)

Anti-Cathepsin K antibody [3F9] (ab37259) is a mouse monoclonal antibody detecting Cathepsin K in Western Blot, Flow Cytometry, IHC-P. Suitable for Human, Mouse.

- Over 30 publications
- Trusted since 2006

View Alternative Names

CTSO, CTSO2, CTSK, Cathepsin K, Cathepsin O, Cathepsin O2, Cathepsin X

3 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin K antibody [3F9] (AB37259)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cathepsin K antibody [3F9] (AB37259)

Bone from mouse foot (bone marrow with osteoclasts (positive). IHC-P image was obtained after deparaffinization, antigen retrieval with 0.1 M EDTA (6-8 min, 72 C), drying of slide before staining (10 min, 62 C), and subsequent staining with primary antibody (1/100) in 1% horse serum (1 h, 37 C).

Flow Cytometry - Anti-Cathepsin K antibody [3F9] (AB37259)
  • Flow Cyt

Unknown

Flow Cytometry - Anti-Cathepsin K antibody [3F9] (AB37259)

Overlay histogram showing U20S cells stained with ab37259 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab37259, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG2b [PLPV219] (ab91366, 2μg/1x106 cells ) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in U20S cells fixed with 4% paraformaldehyde (10 min)/permeabilized in 0.1% PBS-Tween used under the same conditions.

Western blot - Anti-Cathepsin K antibody [3F9] (AB37259)
  • WB

Unknown

Western blot - Anti-Cathepsin K antibody [3F9] (AB37259)

Cathepsin K contains a potential glycosylation site (SwissProt) which may explain its migration at a higher molecular weight than predicted, seen at 40 kDa. The band observed at 25 kDa could potentially be a cleaved form of Cathepsin K due to the presence of both a 15 amino acid signal prptide and a 99 amino acid propeptide. Cathepsin K in its mature form has an expected molecular weight of 25 kDa.

All lanes:

Western blot - Anti-Cathepsin K antibody [3F9] (ab37259) at 1 µg/mL

All lanes:

Human bone tumor tissue lysate - total protein (<a href='/en-us/products/unavailable/human-bone-tumor-tissue-lysate-total-protein-ab29359'>ab29359</a>) at 10 µg

Secondary

All lanes:

Goat polyclonal Secondary Antibody to Mouse IgG - H&L (HRP), pre-adsorbed at 1/3000 dilution

Predicted band size: 37 kDa

Observed band size: 26 kDa,37 kDa,40 kDa

true

Exposure time: 1min

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

3F9

Isotype

IgG2b

Carrier free

Yes

Reacts with

Mouse, Human

Applications

WB, IHC-P, Flow Cyt

applications

Immunogen

Recombinant Fragment Protein within Human CTSK aa 100 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

P43235

Epitope

The monoclonal antibody ab37259 (clone 3F9) reacts with an epitope located between aa 115-329:APDSVDYRKKGYVTPNQGQCGSCWAFSSVGALEGQLKKKTGKLLNLSPQNLVDCVSENDGCGGGYMTNAFQYVQKNRGIDSEDAYPYVGQEESCMYNPTGKAAKCRGYREIPEGNEKALKRAVARVGPVSVAIDASLTSFQFSKGVYYDESCNSDNLNHAVLAVGYGIQKGNKHWIIKNSWGENWGNKGYILMARNKNNACGIANLASFPKM

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1 µg for 10^6 Cells", "FlowCyt-species-notes": "<p><a href='/en-us/products/primary-antibodies/mouse-igg2b-kappa-monoclonal-7e10g10-isotype-control-ab170192'>ab170192</a> - Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody.</p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" }, "Mouse": { "FlowCyt-species-checked": "guaranteed", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>" } } }

Product details

What is this antibody validated in?
Anti-Cathepsin K antibody [3F9] (ab37259) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human, Mouse samples.

What is the molecular weight of Cathepsin K?
Anti-Cathepsin K [3F9] (ab37259) specifically detects a band for Cathepsin K (UniProt: P43235) at a molecular weight of 37kDa.

Trusted by the scientific community
Anti-Cathepsin K [3F9] (ab37259) was first used in a scientific publication in 2006 and has been cited over 30 times in peer-reviewed journals.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Purification notes
Purified from tissue culture supernatant.
Storage buffer
Constituents: PBS, 0.58% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cathepsin K also known as CTSK is a protease enzyme that belongs to the papain family of cysteine proteases. With a molecular weight of approximately 37 kDa Cathepsin K is mainly expressed in osteoclasts which are cells involved in bone resorption. This enzyme functions by cleaving collagen a vital component of bone extracellular matrix which facilitates bone remodeling and turnover. Known for its collagenolytic activity Cathepsin K is important in processes where breakdown of collagen fibers is required.
Biological function summary

Cathepsin K plays a significant role in bone metabolism. It operates within the osteoclasts where it degrades type I collagen and other matrix proteins essential for normal bone maintenance and repair. Cathepsin K does not function as part of a complex but acts independently in its enzymatic role. It is highly specific to substrates found in the bone matrix differentiating it from other cathepsins like cathepsin L or B that may have broader expression and role.

Pathways

Cathepsin K is an important player in the bone remodeling pathway. This pathway involves a series of coordinated actions between osteoclasts and osteoblasts to maintain bone health. Cathepsin K's activity is tightly regulated within this pathway to ensure proper bone density and structure. It is associated with other proteins such as osteopontin and matrix metalloproteinases which work together to modulate bone turnover. Within the RANK/RANKL pathway Cathepsin K acts as a downstream effector following osteoclast activation by RANKL.

Cathepsin K is most notably linked to osteoporosis and pycnodysostosis. Osteoporosis arises due to excessive bone resorption where elevated Cathepsin K activity leads to weakened bone structure increasing fracture risk. Pycnodysostosis is a rare genetic disorder caused by mutations in the gene coding for Cathepsin K resulting in impaired bone resorption and abnormally dense but brittle bones. In these conditions proteins such as RANKL and osteoprotegerin also play critical roles by influencing osteoclast differentiation and activity thereby modulating Cathepsin K's effects.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Thiol protease involved in osteoclastic bone resorption and may participate partially in the disorder of bone remodeling. Displays potent endoprotease activity against fibrinogen at acid pH. May play an important role in extracellular matrix degradation. Involved in the release of thyroid hormone thyroxine (T4) by limited proteolysis of TG/thyroglobulin in the thyroid follicle lumen (PubMed : 11082042).
See full target information CTSK

Publications (45)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 15:27919 PubMed40745459

2025

A variant form of receptor activator of nuclear factor-κB functions as an osteoprotegerin mimic in bone and cardiac development.

Applications

Unspecified application

Species

Unspecified reactive species

Riko Kitazawa,Ryuma Haraguchi,Sohei Kitazawa

Theranostics 15:6719-6736 PubMed40585986

2025

OTUD1 inhibits osteoclast differentiation and osteoclastic bone loss through deubiquitinating and stabilizing PRDX1.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoyu Sun,Tong Wu,Shuhong Chen,Zheyu Zhao,Ruiwei Jia,Jun Ma,Lei Yin,Xingbei Pan,Yifan Ping,Yixin Mao,Lulu Ma,Yilin Ma,Wu Luo,Shengbin Huang,Guang Liang

Bone research 13:60 PubMed40500265

2025

Inflammatory macrophage-derived itaconate inhibits DNA demethylase TET2 to prevent excessive osteoclast activation in rheumatoid arthritis.

Applications

Unspecified application

Species

Unspecified reactive species

Kewei Rong,Dezheng Wang,Xiting Pu,Cheng Zhang,Pu Zhang,Xiankun Cao,Jinglin Zheng,Xiao Yang,Kexin Liu,Lei Shi,Yin Li,Peixiang Ma,Dan Ye,Jie Zhao,Pu Wang,An Qin

Journal of orthopaedic translation 50:158-173 PubMed39876975

2025

A novel application perspective of the clinical-used drug verapamil on osteoporosis via targeting .

Applications

Unspecified application

Species

Unspecified reactive species

Xiankun Cao,Kewei Rong,Yinghua Li,Pu Zhang,Kexin Liu,Lei Cui,Shaotian Fu,Qi Hua,Xiao Yang,Hang Zhang,Xiaofei Cheng,Peixiang Ma,Jie Zhao,An Qin

Nature communications 15:5994 PubMed39013863

2024

ARID1A safeguards the canalization of the cell fate decision during osteoclastogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiahui Du,Yili Liu,Jinrui Sun,Enhui Yao,Jingyi Xu,Xiaolin Wu,Ling Xu,Mingliang Zhou,Guangzheng Yang,Xinquan Jiang

Cell death & disease 15:111 PubMed38316760

2024

IL-17 promotes osteoclast-induced bone loss by regulating glutamine-dependent energy metabolism.

Applications

Unspecified application

Species

Unspecified reactive species

Renpeng Peng,Yimin Dong,Meng Zheng,Honglei Kang,Pengju Wang,Meipeng Zhu,Kehan Song,Wei Wu,Feng Li

Histopathology 83:569-581 PubMed37679051

2023

TSC2 inactivation, low mutation burden and high macrophage infiltration characterise hepatic angiomyolipomas.

Applications

Unspecified application

Species

Unspecified reactive species

Krinio Giannikou,Katarzyna Klonowska,Junko Tsuji,Shulin Wu,Zachary Zhu,Clemens K Probst,Katrina Z Kao,Chin-Lee Wu,Scott Rodig,Adrian Marino-Enriquez,Yoh Zen,Inga-Marie Schaefer,David J Kwiatkowski

British journal of pharmacology 181:429-446 PubMed37625900

2023

Neutrophil extracellular traps mediate bone erosion in rheumatoid arthritis by enhancing RANKL-induced osteoclastogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Ayda Henriques Schneider,Thaise Mayumi Taira,Gabriel Azevedo Públio,Douglas da Silva Prado,Paula Barbim Donate Yabuta,Jéssica Cristina Dos Santos,Caio Cavalcante Machado,Flávio Falcão Lima de Souza,Lucas Gabriel Rodrigues Venturini,Renê Donizeti Ribeiro de Oliveira,Thiago Mattar Cunha,José Carlos Alves-Filho,Paulo Louzada-Júnior,Tarcília Aparecida da Silva,Sandra Yasuyo Fukada,Fernando Queiróz Cunha

Cell death & disease 14:447 PubMed37468461

2023

Loss of function mutation in Ank causes aberrant mineralization and acquisition of osteoblast-like-phenotype by the cells of the intervertebral disc.

Applications

Unspecified application

Species

Unspecified reactive species

Takashi Ohnishi,Victoria Tran,Kimheak Sao,Pranay Ramteke,William Querido,Ruteja A Barve,Koen van de Wetering,Makarand V Risbud

Frontiers in immunology 14:1206099 PubMed37404829

2023

Massively HIV-1-infected macrophages exhibit a severely hampered ability to differentiate into osteoclasts.

Applications

Unspecified application

Species

Unspecified reactive species

Franco A Sviercz,Patricio Jarmoluk,Cintia G Cevallos,Cynthia A M López,Rosa N Freiberger,Alex Guano,Alan Adamczyk,Matías Ostrowski,M Victoria Delpino,Jorge Quarleri
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com